Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1971 4
1972 6
1973 9
1974 10
1975 9
1976 5
1977 8
1978 7
1979 7
1980 5
1981 3
1982 6
1983 3
1984 5
1985 9
1986 5
1987 20
1988 23
1989 28
1990 21
1991 36
1992 14
1993 28
1994 30
1995 33
1996 34
1997 25
1998 25
1999 32
2000 32
2001 29
2002 31
2003 30
2004 34
2005 28
2006 29
2007 14
2008 8
2009 4
2010 2
2011 2
2013 1
2014 1
2016 1
2017 1
2018 1
2019 4
2020 3
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

703 results
Results by year
Filters applied: . Clear all
Page 1
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.
Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity. Neeland IJ, et al. Among authors: fruchart jc. Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10. Lancet Diabetes Endocrinol. 2019. PMID: 31301983 Free article. Review.
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Alberti KG, et al. Among authors: fruchart jc. Circulation. 2009 Oct 20;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. Epub 2009 Oct 5. Circulation. 2009. PMID: 19805654
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart JC, Eckel RH, Matsuzawa Y, Després JP. Ross R, et al. Among authors: fruchart jc. Nat Rev Endocrinol. 2020 Mar;16(3):177-189. doi: 10.1038/s41574-019-0310-7. Epub 2020 Feb 4. Nat Rev Endocrinol. 2020. PMID: 32020062 Free PMC article. Review.
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM. Pradhan AD, et al. Among authors: fruchart jc. Am Heart J. 2018 Dec;206:80-93. doi: 10.1016/j.ahj.2018.09.011. Epub 2018 Sep 29. Am Heart J. 2018. PMID: 30342298 Free article. Review.
Fibrates.
Robillard R, Fontaine C, Chinetti G, Fruchart JC, Staels B. Robillard R, et al. Among authors: fruchart jc. Handb Exp Pharmacol. 2005;(170):389-406. doi: 10.1007/3-540-27661-0_14. Handb Exp Pharmacol. 2005. PMID: 16596808 Review.
SPPARM alpha: the Lazarus effect.
Fruchart JC, Santos RD. Fruchart JC, et al. Curr Opin Lipidol. 2019 Dec;30(6):419-427. doi: 10.1097/MOL.0000000000000640. Curr Opin Lipidol. 2019. PMID: 31577610 Review.
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators. LaRosa JC, et al. Among authors: fruchart jc. N Engl J Med. 2005 Apr 7;352(14):1425-35. doi: 10.1056/NEJMoa050461. Epub 2005 Mar 8. N Engl J Med. 2005. PMID: 15755765 Free article. Clinical Trial.
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators. Nissen SE, et al. Among authors: fruchart jc. JAMA. 2006 Apr 5;295(13):1556-65. doi: 10.1001/jama.295.13.jpc60002. Epub 2006 Mar 13. JAMA. 2006. PMID: 16533939 Clinical Trial.
Pleiotropic effects of fibrates.
Chinetti-Gbaguidi G, Fruchart JC, Staels B. Chinetti-Gbaguidi G, et al. Among authors: fruchart jc. Curr Atheroscler Rep. 2005 Sep;7(5):396-401. doi: 10.1007/s11883-005-0053-x. Curr Atheroscler Rep. 2005. PMID: 16105484 Review.
703 results